With the rise of COVID-19, need for real-time drug supply chain assurance has never been more pressing. While healthcare leaders and front-line workers rally together and fight this disease, we believe that a blockchain-based solution capable of tracking therapeutics, test kits, vaccines, and ventilators is necessary to accelerate their efforts to protect the public.
As part of a peer-reviewed study commissioned by the US FDA and published in Blockchain in Healthcare Today, a Hyperledger Member LedgerDomain and UCLA Health joined forces to deploy and test BRUINchain, a last-mile blockchain-driven solution used by real caregivers to help deliver lifesaving medications. The study is among the first of its kind to reveal exactly how blockchain could save pharmacies billions of dollars in labor and safety stock costs alone.
Since announcing their results from the FDA pilot study, LedgerDomain has been pushing forward on its mission to help pharma supply chain stakeholders build a real-time interoperable system. In a recent virtual technology summit, LedgerDomain brought together partner organizations, key healthcare stakeholders, and visionary technologists to demonstrate their latest milestones. This included a live demo of a micro-app capable of scanning the 2D barcode on any prescription drug in the United States. The Scan Any Drug micro-app makes it possible to instantly access full information about the drug, including recalls, expiration statuses, extended expiration dates, and updated package inserts.
At the high point of the summit, LedgerDomain ran a live load test of Selvedge, its blockchain application server. The live demo proved capable of running 165 net transactions per second, achieved using a single server simulating millions of transactions. This single server then is running at a rate roughly equivalent to all US prescriptions at retail!